Treatment outcome in adults with acute lymphoblastic leukemia: 50% long-term disease-free survival [7]

Leukemia

Volumn 21, Issue 10, 2007, Pages 2203-2204

  Tjonnfjord G E ^a   Gedde Dahl, T ^a   Heldal, D ^a   Brinch, L ^a  

^a UNIVERSITY OF OSLO   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ASPARAGINASE; CYCLOPHOSPHAMIDE; CYTARABINE; DAUNORUBICIN; DOXORUBICIN; GLUCOCORTICOID; MERCAPTOPURINE; METHOTREXATE; PREDNISONE; TIOGUANINE; VINCRISTINE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; ALLOGRAFT; CANCER CHEMOTHERAPY; CANCER SURVIVAL; CENTRAL NERVOUS SYSTEM METASTASIS; CLINICAL PROTOCOL; CONTROLLED STUDY; DISEASE FREE SURVIVAL; DRUG DOSE ESCALATION; DRUG DOSE INCREASE; DRUG MEGADOSE; DRUG RESPONSE; FEMALE; FOLLOW UP; HUMAN; LETTER; LEUKEMIA RELAPSE; LEUKEMIA REMISSION; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; SALVAGE THERAPY; TREATMENT OUTCOME;

EID: 34548799716     PISSN: 08876924     EISSN: 14765551     Source Type: Journal    
DOI: 10.1038/sj.leu.2404751     Document Type: Letter

References (8)

1. Durrant IJ, Prentice HG, Richards SM. Intensification of treatment for adults with acute lymphoblastic leukaemia: Results of UK Medical Research Council randomized trial UKALL XA. Br J Haematol 1997; 99: 84-92.
2. Annino L, Vegna ML, Camera A, Specchia G, Visan G, Fioritoni G et al. Treatment of adult acute lymphoblastic leukaemia (ALL): Longterm follow-up of the GIMEMA ALL 0288 randomized study. Blood 2002; 99: 863-871.
3. Thomas X, Boiron JM, Huguet F, Dombret H, Bradstock K, Vey N et al. Outcome of treatment in adults with acute lymphoblastic leukemia: analysis of the LALA-94 trial. J Clin Oncol 2004; 22: 4075-4086.
4. Rowe JM, Buck G, Burnett AK, Chopra R, Wiernik PH, Richards SM et al. Induction therapy for adults with acute lymphoblastic leukemia: results of more than 1500 patients from the international ALL trial: MRC UKALL XII/ECOG E2993. Blood 2005; 106: 3760-3767.
5. Evensen SA, Brinch L, Tjønnfjord G, Stavern P, Wisløff F. Estimated 8-year survival of more than 40% in a population-based study of 79 adult patients with acute lymphoblastic leukaemia. Br J Hematol 1994; 88: 88-93.
6. Boissel N, Auclerc MF, Lheritier V, Perel Y, Thomas X, Leblanc T et al. Should adolescents with acute lymphoblastic leukaemia be treated as old children or young adults? Comparison of the French FRALL-93 and LALA-94 trials. J Clin Oncol 2003; 21: 774-780.
7. de Bont JM, van der Holt B, Dekker W, van der Does-van den Berg A, Sonneveld P, Pieters R. Significant differences in outcome for adolescents with acute lymphoblastic leukaemia treated on pediatric vs adult protocols in the Netherlands. Leukemia 2004; 18: 2032-2035.
8. Hallböök H. Acute lymphoblastic leukaemia in adult patients. Studies of prognostic factors, treatment results and in vitro cellular drug resistance. Series of Dissertations, Acta Universitatis Upsaliensis 2005. Available at AUU (accessed 07.08.06): http://urn.kb.se/resolve?urn=urn:nBn:se:uu:diva-5768.